Head-To-Head Survey: Joint (NASDAQ:JYNT) versus Oscar Health (NYSE:OSCR)

Oscar Health (NYSE:OSCR) and Joint (NASDAQ:JYNT) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Earnings & Valuation

This table compares Oscar Health and Joint”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.70 billion	0.85	-$443.15 million	$1.40	23.03
Joint	$54.90 million	2.23	$2.91 million	$0.27	32.05

Joint has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Oscar Health and Joint’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oscar Health	3.60%	38.45%	6.76%
Joint	6.49%	12.02%	3.47%

Insider and Institutional Ownership

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 22.6% of Oscar Health shares are held by company insiders. Comparatively, 30.2% of Joint shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Oscar Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the S&P 500. Comparatively, Joint has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for Oscar Health and Joint, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	0	8	3	1	2.42
Joint	0	3	0	0	2.00

Oscar Health currently has a consensus price target of $26.22, suggesting a potential downside of 18.68%. Given Oscar Health’s stronger consensus rating and higher possible upside, equities analysts plainly believe Oscar Health is more favorable than Joint.

Summary

Oscar Health beats Joint on 9 of the 15 factors compared between the two stocks.

About Oscar Health

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.